Celyad Oncology SA
EBR:CYAD.BR
0.25 (EUR) • At close September 19, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -8.448 | -40.935 | -26.512 | -17.204 | -28.632 | -37.427 | -43.119 | -23.606 | -29.114 | -16.453 | -12.346 | -13.524 |
| Afschrijvingen & Amortisatie
| 0.794 | 1.44 | 1.52 | 1.832 | 1.788 | 1.114 | 9.004 | 1.516 | 1.033 | 0.87 | 0.886 | 0.894 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | -0.531 | 1.049 | 0.085 | 0 | 0 | -0.168 | -0.006 | -0.539 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0.935 | 1.624 | 2.172 | 2.782 | 2.775 | 3.595 | 2.569 | 2.847 | 0.795 | 1.098 | 0.274 | 0.151 |
| Verandering in Werkkapitaal
| -6.498 | -4.015 | 1.405 | -2.874 | -0.609 | 0.481 | -21.302 | -1.758 | 1.719 | 0.028 | -0.205 | -0.393 |
| Vorderingen
| -1.205 | 0.306 | 0 | 0 | -1.772 | -1.459 | -0.832 | -1.018 | 0.653 | -2.048 | -0.452 | 0 |
| Voorraden
| 0 | 0 | 0 | 0 | 1.772 | -0.481 | 3.314 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| 0 | -4.321 | 2.964 | -1.726 | 1.163 | 1.94 | -2.482 | -0.74 | 1.066 | 0 | 0 | 0 |
| Overig Werkkapitaal
| -6.498 | 0.306 | -1.559 | -1.148 | -1.772 | -1.459 | -17.988 | 0 | 0 | 2.076 | 0.247 | 0 |
| Overige Niet-Contante Posten
| 0.538 | 13.876 | -4.697 | -13.25 | -3.609 | 4.988 | 3.3 | -3.523 | -1.73 | -2.418 | 0.753 | 4.536 |
| Kasstroom uit Operationele Activiteiten
| -15.202 | -28.01 | -26.643 | -27.665 | -28.202 | -27.249 | -49.548 | -24.692 | -27.303 | -17.414 | -10.638 | -8.337 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -0.934 | -0.123 | -0.393 | -0.319 | -0.622 | -1.765 | -0.858 | -1.782 | -0.838 | -0.64 | -0.531 | -0.657 |
| Netto Overnames
| 1.341 | 6 | 0 | 0.235 | 0 | 0.932 | -5.107 | -1.56 | -5.186 | -1.5 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | 0 | 0 | -0.476 | 0 | -26.561 | -10.749 | -34.23 | -5 | 0.372 | -3 | 0 |
| Verkoop/verval van Beleggingen
| 0 | 1.09 | 0 | 0.241 | 9.379 | 28.859 | 34.326 | 7.338 | 0.333 | 0.372 | 0 | 0 |
| Overige Investeringsactiviteiten
| 1.306 | 0.235 | 0.267 | 0.476 | 0.23 | -0.858 | 5.108 | 0.077 | -4.694 | -0.372 | -3.459 | 0 |
| Kasstroom uit Investeringsactiviteiten
| 0.407 | 7.202 | -0.126 | 0.157 | 8.987 | 0.607 | 22.72 | -30.157 | -10.691 | -1.768 | -3.531 | -0.657 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| -0.145 | -0.896 | -1.136 | -1.447 | -1.487 | -0.749 | -0.576 | -0.399 | -0.188 | -0.138 | -0.163 | -0.291 |
| Uitgifte van Gewone Aandelen
| 9.49 | 0 | 36.568 | 0 | 16.448 | 43.011 | 0.625 | 0 | 109.154 | 25.305 | 30.623 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | -0.124 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 0.01 | 4.261 | 4.089 | 6.843 | 3.315 | 1.666 | 0.556 | 3.43 | 1.569 | 2.59 | 1.123 | 9.179 |
| Kasstroom uit Financieringsactiviteiten
| 9.355 | 3.241 | 39.521 | 5.396 | 18.276 | 43.928 | 0.605 | 3.031 | 110.535 | 27.757 | 31.583 | 8.887 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| -0.001 | -0.006 | 0.032 | 0.008 | -0.265 | 0.003 | 1.12 | 0.001 | 0.001 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -5.441 | -17.573 | 12.784 | -22.104 | -1.204 | 17.289 | -25.104 | -51.817 | 72.542 | 8.575 | 17.413 | -0.106 |
| Kaspositie aan het Einde van de Periode
| 7.004 | 12.445 | 30.018 | 17.234 | 39.338 | 40.542 | 23.253 | 48.357 | 100.175 | 27.633 | 19.058 | 1.645 |